Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Rockwell Medical (RMTI) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $1.6 million.

  • Rockwell Medical's Accumulated Depreciation & Amortization rose 54.98% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 54.98%. This contributed to the annual value of $2.2 million for FY2024, which is 5096.95% up from last year.
  • Per Rockwell Medical's latest filing, its Accumulated Depreciation & Amortization stood at $1.6 million for Q3 2025, which was up 54.98% from $1.1 million recorded in Q2 2025.
  • Rockwell Medical's Accumulated Depreciation & Amortization's 5-year high stood at $2.2 million during Q4 2024, with a 5-year trough of $138000.0 in Q1 2022.
  • Its 5-year average for Accumulated Depreciation & Amortization is $777684.2, with a median of $545000.0 in 2024.
  • As far as peak fluctuations go, Rockwell Medical's Accumulated Depreciation & Amortization crashed by 3168.32% in 2022, and later skyrocketed by 24062.5% in 2024.
  • Rockwell Medical's Accumulated Depreciation & Amortization (Quarter) stood at $668000.0 in 2021, then dropped by 13.77% to $576000.0 in 2022, then surged by 150.69% to $1.4 million in 2023, then surged by 50.97% to $2.2 million in 2024, then fell by 24.5% to $1.6 million in 2025.
  • Its Accumulated Depreciation & Amortization was $1.6 million in Q3 2025, compared to $1.1 million in Q2 2025 and $539000.0 in Q1 2025.